Leerink Partnrs Predicts Gilead Sciences Q1 Earnings
Equities researchers at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Gilead Sciences in a report ...
Hosted on MSN11h
US Equity Indexes Rise in Week Amid Tariff Tumult, Hot Inflation, Fed on Pause
US equity indexes rose this week as investors weighed the Trump administration's global punitive tariffs policy, and Federal Reserve Chair Jerome Powell reiterated there's no hurry to lower interest ...
Gilead Sciences Inc. stock underperforms Friday when compared to competitors
The stock's fall snapped a three-day winning streak.
Maxim Group Reaffirms Their Hold Rating on Gilead Sciences (GILD)
Maxim Group analyst Michael Okunewitch maintained a Hold rating on Gilead Sciences (GILD – Research Report) today. The company’s shares closed ...
Dividend Roundup: Meta Platforms, Nike, Ford, Johnson & Johnson, and more
This week's dividend activity included increased payouts from Gilead Sciences (GILD) and Meta Platforms (NASDAQ:META) as well as declarations from companies such as Nike (NYSE:NKE) and Unilever (UL).
OCT West Coast 2025: Patient and site centricity go hand-in-hand
It is vital for sponsors to reduce the burden on the site if they also want to lessen the strain on patients, said Shantheri Pai, associate director clinical operations for oncology at Gilead while ...